Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

Short Parkinson's Evaluation Scale (SPES)/Scales for Outcomes in Parkinson’s Disease – Motor Function (SPES/SCOPA – Motor)


Acronym: SPES/SCOPA – Motor

Authors: Marinus J, Visser M, Stiggelbout AM, Rabey JM, Martínez-Martín P, Bonuccelli U, Kraus PH, van Hilten JJ.

The SPES/SCOPA is a short, reliable, and valid scale used to evaluate the motor function of PD patients and includes three sections: A) Motor evaluation (10 items, maximum of 42 points), B) Activities of Daily Living (7 items, 21 points), and C) Motor Complications (4 items, 12 points – with 2 items on motor fluctuations [6 points] and 2 on dyskinesias [6 points]). Response options for all items range 0 to 3.

The development of the SPES/SCOPA is part of a larger research project, the SCales for Outcomes in PArkinson’s disease (SCOPA), in which practical and clinimetric sound instruments for all relevant regions in PD are selected or developed. The SCOPA instruments were originally developed in the Dutch language. 

Original PublicationView the Scale (PDF)

To request permission to use this Rating Scale, please fill out a Permission Request Form.​​​​​​​  

Year Published: 2004

Last Updated: Unchanged since publication

Instrument Type: ClinRO and PRO

Estimated Time to Complete: 8-10 minutes

Available Translations:

Related Publications:

Verbaan D, van Rooden SM, Benit CP, van Zwet EW, Marinus J, van Hilten JJ. SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease. Parkinsonism related Disorders. 2011 Sep; 17(8): 632-634.

Martinez-Martin P et al. The SCOPA–Motor Scale for assessment of Parkinson’s disease is a consistent and valid measure. J Clin Epidemiol 2005;58:674-9.

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice